MA-BATTERY-VENTURES
26.3.2024 12:01:26 CET | Business Wire | Press release
Battery Ventures, a global, technology-focused investment firm, today announced a significant investment in Mobius Institute (“Mobius”), a company that specializes in reliability improvement, conditioning-monitoring, and precision-maintenance training and certification.
Mobius delivers its training via public, in-plant, and online training programs and has trained more than 70,000 professionals from 180 countries since 2005. In addition to training, a related entity to the company, Mobius Institute Board of Certification, is an ISO/IEC 17024 and ISO 18436-accredited certification body that provides globally recognized certification to reliability professionals, vibration analysts, ultrasound analysts, thermal imaging, and lubrication specialists worldwide.
Mobius Institute is seen as an authority in the industrial asset-reliability space, which is growing in importance as companies transition to predictive and data-based maintenance regimes to operate more efficiently and meet new sustainability targets. Via its network of training partners, Mobius has trained maintenance and reliability professionals across a wide range of industries with students from Pfizer, Rio Tinto, Abbott, Abbvie, Ford, Coca-Cola, Samsung, ABB, Cargill, Nestle, Siemens, Dow, Amazon, Bayer, Mercedes-Benz, NASA, and Hyundai, among others.
Jason Tranter, the co-founder of Mobius, said he hoped the partnership with Battery will help his company scale to a new level. “My wife, Georgie, and I started the business in our house in 1999 with the goal of making vibration analysis and condition monitoring understandable. We never imagined Mobius Institute growing to this scale with almost 10,000 students trained last year alone,” he said. “Having developed a relationship with Battery over the past several years, I am excited to see Mobius continue to grow under Battery’s ownership as the starting point of a new platform.”
As part of the transaction, Tranter will serve as a technical advisor to Mobius.
Battery’s goal with the transaction is to create a large, innovative, asset-reliability and industrial-services player; the firm expects to build upon Mobius’ strength in asset reliability while expanding the portfolio into the broader market for industrial training, certification, and specialized products & services.
As part of this initiative, Marcus Pillion joins the company as Group CEO to drive M&A and continued organic growth, as well as to oversee integration efforts. Pillion joins Mobius after serving most recently as the CEO of Des-Case before its acquisition by Timken (NYSE: TKR) in 2023. Prior to Des-Case, Pillion had previous executive experience across several asset-reliability and condition-monitoring businesses including TRITEC Performance Solutions, Colfax Fluid Handling, EagleBurgmann, SKF and John Crane.
“I am excited to join forces with Battery, a seasoned industrial-technology investor with extensive experience creating platforms through global M&A,” said Pillion. “Having used Mobius Institute training across all of the companies I previously worked for, I am excited to build upon the global brand Mobius has created as we enter into the next phase of its growth trajectory.”
“We are thrilled to partner with Mobius and its exceptional staff as we pursue the next phase of growth for the business,” said Zack Smotherman, a Battery general partner. “Having followed the asset-reliability and condition-monitoring market for many years, we’ve observed an accelerating trend in predictive maintenance and believe we are still in the early innings of this movement as many industries increasingly adopt these solutions.”
Added Battery Principal Justin Rosner: “We are grateful to Jason for the opportunity to partner with Mobius and excited about the journey ahead as we look to leverage Mobius’s global reputation to improve asset reliability across many industries in the years to come.”
About Mobius Institute
Mobius Institute is a worldwide provider of reliability improvement, condition monitoring, and precision maintenance education to industrial plant managers, reliability engineers, and condition monitoring specialists, allowing plants to be successful in implementing reliability improvement and condition monitoring programs. Mobius delivers its training via public, in-person / onsite, and online education programs with a key advantage being its unique training style that uses innovative 3D animations and software simulations, making complex topics easier to understand. Mobius has trained and certified more than 70,000 industrial professionals from 180 countries since 2005 with thousands more engaged through distance learning programs and Mobius’ online community MOBIUS CONNECT. Learn more at https://www.mobiusinstitute.com/about-mobius-institute/.
About Battery
Battery partners with exceptional founders and management teams developing category-defining businesses in markets including software and services, enterprise infrastructure, consumer tech, healthcare IT and industrial technology and life-science tools. Founded in 1983, the firm backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from offices in Boston, San Francisco, Menlo Park, New York, London, and Tel Aviv. Follow the firm on X @BatteryVentures, visit our website at www.battery.com and find a full list of Battery's portfolio companies here.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240326724392/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom